|
2019 Journal Article Postoperative pain and comfort scores: Do they correlate?Miu, Michelle W., Martin, Andrew and Cyna, Allan M. (2019). Postoperative pain and comfort scores: Do they correlate?. Anaesthesia and Intensive Care, 47 (5), 435-441. doi: 10.1177/0310057X19861985 |
|
2019 Journal Article Assumptions, damn assumptions and statisticsSimes, R. J. and Martin, A. J. (2019). Assumptions, damn assumptions and statistics. Annals of Oncology, 30 (9), 1415-1416. doi: 10.1093/annonc/mdz209 |
|
2019 Journal Article Enzalutamide with standard first-line therapy in metastatic prostate cancerDavis, Ian D., Martin, Andrew J., Stockler, Martin R., Begbie, Stephen, Chi, Kim N., Chowdhury, Simon, Coskinas, Xanthi, Frydenberg, Mark, Hague, Wendy E., Horvath, Lisa G., Joshua, Anthony M., Lawrence, Nicola J., Marx, Gavin, McCaffrey, John, McDermott, Ray, McJannett, Margaret, North, Scott A., Parnis, Francis, Parulekar, Wendy, Pook, David W., Neil Reaume, M., Sandhu, Shahneen K., Tan, Alvin, Hsiang Tan, T., Thomson, Alastair, Tu, Emily, Vera-Badillo, Francisco, Williams, Scott G., Yip, Sonia ... for the ENZAMET Trial Investigators and the Australian and New Zealand Urogenital and Prostate Cancer Trials Group (2019). Enzalutamide with standard first-line therapy in metastatic prostate cancer. New England Journal of Medicine, 381 (2), 121-131. doi: 10.1056/NEJMoa1903835 |
|
2019 Journal Article The Chest Australia Trial: A randomised controlled trial of an intervention to increase consultation rates in smokers at risk of lung cancerEmery, Jon D., Murray, Sonya R., Walter, Fiona M., Martin, Andrew, Goodall, Stephen, Mazza, Danielle, Habgood, Emily, Kutzer, Yvonne, Barnes, David John and Murchie, Peter (2019). The Chest Australia Trial: A randomised controlled trial of an intervention to increase consultation rates in smokers at risk of lung cancer. Thorax, 74 (4), 362-370. doi: 10.1136/thoraxjnl-2018-212506 |
|
2019 Journal Article Neurocognitive function and quality of life outcomes in the ONTRAC study for skin cancer chemoprevention by nicotinamideMartin, Andrew J., Dhillon, Haryana M., Vardy, Janette L., Dalziell, Robyn A., Choy, Bonita, Fernández-Peñas, Pablo, Dixon, Ann, Renton, Corrinne, St. George, Gayathri, Chinniah, Niranthari, Halliday, Gary M., Damian, Diona L. and Chen, Andrew C. (2019). Neurocognitive function and quality of life outcomes in the ONTRAC study for skin cancer chemoprevention by nicotinamide. Geriatrics, 4 (1) 31, 1-6. doi: 10.3390/geriatrics4010031 |
|
2019 Journal Article Predicting chemotherapy toxicity in older adults: Comparing the predictive value of the CARG Toxicity Score with oncologists’ estimates of toxicity based on clinical judgementMoth, Erin B., Kiely, Belinda E., Stefanic, Natalie, Naganathan, Vasikaran, Martin, Andrew, Grimison, Peter, Stockler, Martin R., Beale, Philip and Blinman, Prunella (2019). Predicting chemotherapy toxicity in older adults: Comparing the predictive value of the CARG Toxicity Score with oncologists’ estimates of toxicity based on clinical judgement. Journal of Geriatric Oncology, 10 (2), 202-209. doi: 10.1016/j.jgo.2018.08.010 |
|
2019 Journal Article Oncologists’ perceptions on the usefulness of geriatric assessment measures and the CARG toxicity score when prescribing chemotherapy for older patients with cancerMoth, Erin B., Kiely, Belinda E., Stefanic, Natalie, Naganathan, Vasikaran, Martin, Andrew, Grimison, Peter, Stockler, Martin R., Beale, Philip and Blinman, Prunella (2019). Oncologists’ perceptions on the usefulness of geriatric assessment measures and the CARG toxicity score when prescribing chemotherapy for older patients with cancer. Journal of Geriatric Oncology, 10 (2), 210-215. doi: 10.1016/j.jgo.2018.11.004 |
|
2019 Journal Article The impact of ethnicity on efficacy and toxicity of cyclin D kinase 4/6 inhibitors in advanced breast cancer: a meta-analysisLee, Kirsty Wai Chung, Lord, Sally, Finn, Richard S., Lim, Elgene, Martin, Andrew, Loi, Sherene, Lynch, Jodi, Friedlander, Michael and Lee, Chee Khoon (2019). The impact of ethnicity on efficacy and toxicity of cyclin D kinase 4/6 inhibitors in advanced breast cancer: a meta-analysis. Breast Cancer Research and Treatment, 174 (1), 271-278. doi: 10.1007/s10549-018-5054-x |
|
2019 Journal Article A Reduction in Inflammatory Macrophages May Contribute to Skin Cancer Chemoprevention by NicotinamideMinocha, Rashi, Martin, Andrew J., Chen, Andrew C., Scolyer, Richard A., Lyons, J. Guy, McKenzie, Catriona A., Madore, Jason, Halliday, Gary M. and Damian, Diona L. (2019). A Reduction in Inflammatory Macrophages May Contribute to Skin Cancer Chemoprevention by Nicotinamide. Journal of Investigative Dermatology, 139 (2), 467-469. doi: 10.1016/j.jid.2018.08.018 |
|
2019 Journal Article Treatments used for obsessive–compulsive disorder—An international perspectiveBrakoulias, Vlasios, Starcevic, Vladan, Albert, Umberto, Arumugham, Shyam Sundar, Bailey, Brenda E., Belloch, Amparo, Borda, Tania, Dell'Osso, Liliana, Elias, Jason A., Falkenstein, Martha J., Ferrao, Ygor A., Fontenelle, Leonardo F., Jelinek, Lena, Kalogeraki, Leto, Kay, Brian, Laurito, Luana D., Lochner, Christine, Maina, Giuseppe, Marazziti, Donatella, Martin, Andrew, Matsunaga, Hisato, Miguel, Euripedes C., Morgado, Pedro, Mourikis, Irakis, Pasquini, Massimo, Perez Rivera, Rodrigo, Potluri, Sriramya, Reddy, Janardhan Y.C., Riemann, Brian C. ... Fineberg, Naomi A. (2019). Treatments used for obsessive–compulsive disorder—An international perspective. Human Psychopharmacology, 34 (1) e2686, 1-10. doi: 10.1002/hup.2686 |
|
2018 Journal Article Effect Sizes Hypothesized and Observed in Contemporary Phase III Trials of Targeted and Immunological Therapies for Advanced CancerLawrence, Nicola Jane, Roncolato, Felicia, Martin, Andrew, Simes, Robert John and Stockler, Martin R. (2018). Effect Sizes Hypothesized and Observed in Contemporary Phase III Trials of Targeted and Immunological Therapies for Advanced Cancer. JNCI Cancer Spectrum, 2 (4) pky037, 1-7. doi: 10.1093/JNCICS/PKY037 |
|
2018 Journal Article Protocol for the Lactoferrin Infant Feeding Trial (LIFT): A randomised trial of adding lactoferrin to the feeds of very-low birthweight babies prior to hospital dischargeMartin, Andrew, Ghadge, Alpana, Manzoni, Paolo, Lui, Kei, Brown, Rebecca, Tarnow-Mordi, William, Lu, Kei, Simes, John, Hague, Wendy, Osborn, David, Deshpande, Girish, Kochar, Anu, Lewis, Tony, Watkins, Andrew, Pritchard, Margo, Schofield, Deborah, Mohamed, Abdel Latif, Soll, Roger, Darlow, Brian, Isaacs, David, Wilkinson, Dominic, Wood, Alicia, McKenzie, Anne, Despande, Girish, Verry, Hannah, Wright, Ian, Askie, Lisa, Cruz, Melinda, Berry, Nina ... Espinoza, David (2018). Protocol for the Lactoferrin Infant Feeding Trial (LIFT): A randomised trial of adding lactoferrin to the feeds of very-low birthweight babies prior to hospital discharge. BMJ Open, 8 (10) e023044. doi: 10.1136/bmjopen-2018-023044 |
|
2018 Journal Article Protocol for the P3BEP trial (ANZUP 1302): An international randomised phase 3 trial of accelerated versus standard BEP chemotherapy for adult and paediatric male and female patients with intermediate and poor-risk metastatic germ cell tumoursLawrence, Nicola J., Chan, Howard, Toner, Guy, Stockler, Martin R., Martin, Andrew, Yip, Sonia, Wong, Nicole, Yeung, Annie, Mazhar, Danish, Pashankar, Farzana, Frazier, Lindsay, McDermott, Ray, Walker, Roderick, Tan, Hsiang, Davis, Ian D. and Grimison, Peter (2018). Protocol for the P3BEP trial (ANZUP 1302): An international randomised phase 3 trial of accelerated versus standard BEP chemotherapy for adult and paediatric male and female patients with intermediate and poor-risk metastatic germ cell tumours. BMC Cancer, 18 (1) 854, 1-6. doi: 10.1186/s12885-018-4745-3 |
|
2018 Journal Article The LEAD study protocol: A mixed-method cohort study evaluating the lung cancer diagnostic and pre-treatment pathways of patients from Culturally and Linguistically Diverse (CALD) backgrounds compared to patients from Anglo-Australian backgroundsMazza, Danielle, Lin, Xiaoping, Walter, Fiona M., Young, Jane M., Barnes, David J., Mitchell, Paul, Brijnath, Bianca, Martin, Andrew and Emery, Jon D. (2018). The LEAD study protocol: A mixed-method cohort study evaluating the lung cancer diagnostic and pre-treatment pathways of patients from Culturally and Linguistically Diverse (CALD) backgrounds compared to patients from Anglo-Australian backgrounds. BMC Cancer, 18 (1) 754, 1-8. doi: 10.1186/s12885-018-4671-4 |
|
2018 Journal Article Optimizing live kidney donor workup: A decision analysis approachCheng, Jian Y., Martin, Andrew, Ramanathan, Ganesh and Cooper, Bruce A. (2018). Optimizing live kidney donor workup: A decision analysis approach. Transplantation Direct, 4 (5) e340, 5. doi: 10.1097/TXD.0000000000000777 |
|
2018 Journal Article Health-related quality of life associated with regorafenib treatment in refractory advanced gastric adenocarcinomaMartin, Andrew J., Gibbs, Emma, Sjoquist, Katrin, Pavlakis, Nick, Simes, John, Price, Tim, Shannon, Jenny, Gill, Sanjeev, Jain, Vikram, Liu, Geoffrey, Kannourakis, George, Kim, Yeul Hong, Kim, Jin Won and Goldstein, David (2018). Health-related quality of life associated with regorafenib treatment in refractory advanced gastric adenocarcinoma. Gastric Cancer, 21 (3), 473-480. doi: 10.1007/s10120-017-0754-1 |
|
2018 Journal Article Effect of three- vs four-dimensional ultrasonography on maternal attachmentBenzie, R. J., Starcevic, V., Viswasam, K., Kennedy, N. J., Mein, B. J., Wye, D. A. and Martin, A. (2018). Effect of three- vs four-dimensional ultrasonography on maternal attachment. Ultrasound in Obstetrics and Gynecology, 51 (4), 558-559. doi: 10.1002/uog.17567 |
|
2018 Journal Article Patients' preferences for adjuvant sorafenib after resection of renal cell carcinoma in the SORCE trial: What makes it worthwhile?Blinman, P. L., Davis, I. D., Martin, A., Troon, S., Sengupta, S., Hovey, E., Coskinas, X., Kaplan, R., Ritchie, A., Meade, A., Eisen, T. and Stockler, M. R. (2018). Patients' preferences for adjuvant sorafenib after resection of renal cell carcinoma in the SORCE trial: What makes it worthwhile?. Annals of Oncology, 29 (2), 370-376. doi: 10.1093/annonc/mdx715 |
|
2018 Journal Article How do oncologists make decisions about chemotherapy for their older patients with cancer? A survey of Australian oncologistsMoth, E. B., Kiely, B. E., Naganathan, V., Martin, A. and Blinman, P. (2018). How do oncologists make decisions about chemotherapy for their older patients with cancer? A survey of Australian oncologists. Supportive Care in Cancer, 26 (2), 451-460. doi: 10.1007/s00520-017-3843-0 |
|
2018 Journal Article What survival benefits are needed to make adjuvant sorafenib worthwhile after resection of intermediate- or high-risk renal cell carcinoma? Clinical investigators' preferences in the SORCE trialLawrence, Nicola J., Martin, Andrew, Davis, Ian D., Troon, Simon, Sengupta, Shomik, Hovey, Elizabeth, Coskinas, Xanthi, Kaplan, Richard, Smith, Benjamin, Ritchie, Alastair, Meade, Angela, Eisen, Tim, Blinman, Prunella and Stockler, Martin R. (2018). What survival benefits are needed to make adjuvant sorafenib worthwhile after resection of intermediate- or high-risk renal cell carcinoma? Clinical investigators' preferences in the SORCE trial. Kidney Cancer, 2 (2), 123-131. doi: 10.3233/KCA-180038 |
